Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...

Investors with a lot of money to spend have taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the positions showed up on publicly available ...

DexCom, Inc. DXCM reported fourth-quarter 2024 ... The broader S&P 500 Index has moved up 10% in the same period. Image Source: Zacks Investment Research Sensor and other revenues (96% of total ...

Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...